Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Geert R. van Pottelberge"'
Autor:
Arvind Gharbharan, Carlijn C. E. Jordans, Corine GeurtsvanKessel, Jan G. den Hollander, Faiz Karim, Femke P. N. Mollema, Janneke E. Stalenhoef – Schukken, Anthonius Dofferhoff, Inge Ludwig, Adrianus Koster, Robert-Jan Hassing, Jeannet C. Bos, Geert R. van Pottelberge, Imro N. Vlasveld, Heidi S. M. Ammerlaan, Elena M. van Leeuwen – Segarceanu, Jelle Miedema, Menno van der Eerden, Thijs J. Schrama, Grigorios Papageorgiou, Peter te Boekhorst, Francis H. Swaneveld, Yvonne M. Mueller, Marco W. J. Schreurs, Jeroen J. A. van Kampen, Barry Rockx, Nisreen M. A. Okba, Peter D. Katsikis, Marion P. G. Koopmans, Bart L. Haagmans, Casper Rokx, Bart J. A. Rijnders
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-12 (2021)
There are currently no drugs available to treat SARS-CoV-2 infection. A promising alternative treatment for COVID-19 patients is convalescent plasma. Here, Gharbharan et al. collect covalescent plasma and report no overall clinical benefit for 86 pat
Externí odkaz:
https://doaj.org/article/a6dfe323ebd74308ad646da02ba72d20
Autor:
Arvind Gharbharan, Jeannet C. Bos, Peter te Broekhorst, Inge Ludwig, Faiz Karim, Femke P N Mollema, Janneke E. Stalenhoef, Jan G den Hollander, Elena Segarceanu, Jelle R. Miedema, Carlijn C E Jordans, Corine H. GeurtsvanKessel, Imro N. Vlasveld, Geert R. van Pottelberge, Anton S M Dofferhoff, Grigorios Papageorgiou, Bart L. Haagmans, Nisreen M.A. Okba, Marion Koopmans, Heidi S. M. Ammerlaan, Francis H. Swaneveld, Menno M. van der Eerden, Bart J. A. Rijnders, Robert-Jan Hassing, Peter D. Katsikis, Casper Rokx, Ad Koster, Yvonne M. Mueller
Structured abstract for full paperBackgroundAfter recovery from COVID-19, most patients have anti-SARS-CoV-2 neutralizing antibodies. Their convalescent plasma could be an inexpensive and widely available treatment for COVID-19.MethodsThe Convalescen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af56feb244e78b0078e2e74bd113a776
Publikováno v:
Nijkamp and Parnham's Principles of Immunopharmacology ISBN: 9783030108090
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29b5df272aa812defd9053ef8bbe7f65
https://doi.org/10.1007/978-3-030-10811-3_5
https://doi.org/10.1007/978-3-030-10811-3_5
Autor:
Fien M. Verhamme, Pieter S. Hiemstra, Ken R. Bracke, Guy Joos, Guy Brusselle, Geert R. Van Pottelberge, Geert M Verleden, Gimano D. Amatngalim
Publikováno v:
European Respiratory Journal, 43(4), 1028-1041
Activin-A is a pleiotropic cytokine belonging to the transforming growth factor-β superfamily and has been implicated in asthma and pulmonary fibrosis. However, the role of activin-A and its endogenous inhibitor, follistatin, in the pathogenesis of
Autor:
Bruno H. Ch. Stricker, Frank J. A. van Rooij, Guy Brusselle, Albert Hofman, Katia M.C. Verhamme, Guy Joos, Yannick M.T.A. van Durme, Geert R. Van Pottelberge, Theo Stijnen
Publikováno v:
Chest. 135:368-377
Background: COPD is a major cause of chronic morbidity and mortality throughout the world. Although the prevalence of COPD is already well documented, there are only few studies regarding the incidence of COPD. Methods: In a prospective population-ba
Autor:
Geert R. Van Pottelberge, Guy Joos, Bruno H. Stricker, Guy Brusselle, Albert Hofman, Katia M.C. Verhamme, Jacqueline C.M. Witteman, Yannick M.T.A. van Durme, Albert-Jan L.H.J. Aarnoudse
Publikováno v:
American Journal of Respiratory and Critical Care Medicine, 179(5), 375-382. American Thoracic Society
Rationale Chronic obstructive pulmonary disease (COPD) is characterized by substantial chronic inflammation in the pulmonary compartment as well as in the systemic circulation. Objectives: To investigate potentially causal association, we examined wh
Autor:
Nico Van De Veire, Johan De Sutter, Geert R. Van Pottelberge, Frederic Van Heuverswijn, Thierry C. Gillebert, Olivier De Winter
Publikováno v:
European journal of heart failure
Background: Patients with coronary artery disease (CAD), a QRS duration ≥120 ms and left ventricular ejection fraction (LVEF) ≤30% are potential candidates for cardiac resynchronization therapy (CRT). Our aim was to investigate the relationship b
Publikováno v:
A21. FIRST RESPONDERS: MUCOSAL INNATE IMMUNITY.
Disease-causing mutations in the transcription factor interferon regulatory factor 8 (IRF8) gene impair differentiation of mononuclear phagocytes into dendritic cells (DC) and confer susceptibility to mycobacterial disease. In autosomal recessive IRF
Publikováno v:
Principles of Immunopharmacology ISBN: 9783034601351
Dendritic cells (DCs) were first described in human skin by Paul Langerhans in 1868 [1]. Their function remained unknown until 1973, when it was shown that DCs have a unique immunological key function: they are capable of presenting ANTIGENS to LYMPH
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::055dfb092467a34a12e83bf8e460c97d
https://doi.org/10.1007/978-3-0346-0136-8_4
https://doi.org/10.1007/978-3-0346-0136-8_4
Autor:
Jo Vandesompele, Guy Joos, Guy Brusselle, Yannick M.T.A. van Durme, Olivier Thas, Ken R. Bracke, Pieter Mestdagh, Geert R. Van Pottelberge
Publikováno v:
American journal of respiratory and critical care medicine. 183(7)
Chronic obstructive pulmonary disease (COPD) is characterized by progressive inflammation in the airways and lungs combined with disturbed homeostatic functions of pulmonary cells. MicroRNAs (miRNAs) have the ability to regulate these processes by in